Lantheus Holdings, Inc. (LNTH) stock
LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3010% above fair value
$101.59+0.34 (+0.34%)
Close on Nov 13, 2026Market cap $6.63BP/E 25.1Yield –
Lantheus total assets
Total assets on the balance sheet at the end of each period.
Lantheus's total assets was $2.46B at Sep 30, 2026. For fiscal 2025 it was $2.23B, up 12.5% from the year before. Over ten years it grew 24.8% a year on average. The highest annual figure on record is $2.23B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.23B | +12.5% |
| FY2024 | Dec 31, 2024 | $1.98B | +19.9% |
| FY2023 | Dec 31, 2023 | $1.65B | +25.0% |
| FY2022 | Dec 31, 2022 | $1.32B | +53.0% |
| FY2021 | Dec 31, 2021 | $863.78M | -0.7% |
| FY2020 | Dec 31, 2020 | $869.82M | +114.3% |
| FY2019 | Dec 31, 2019 | $405.92M | -7.7% |
| FY2018 | Dec 31, 2018 | $439.83M | +14.6% |
| FY2017 | Dec 31, 2017 | $383.86M | +50.0% |
| FY2016 | Dec 31, 2016 | $255.90M | +5.6% |
| FY2015 | Dec 31, 2015 | $242.38M | -0.3% |
| FY2014 | Dec 31, 2014 | $243.15M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.46B | +7.9% |
| Q2 FY2026 | Jun 30, 2026 | $2.41B | +14.1% |
| Q1 FY2026 | Mar 31, 2026 | $2.35B | +14.2% |
| Q4 FY2025 | Dec 31, 2025 | $2.23B | +12.5% |
| Q3 FY2025 | Sep 30, 2025 | $2.28B | +11.1% |
| Q2 FY2025 | Jun 30, 2025 | $2.12B | +9.1% |
| Q1 FY2025 | Mar 31, 2025 | $2.06B | +12.2% |
| Q4 FY2024 | Dec 31, 2024 | $1.98B | +19.9% |
| Q3 FY2024 | Sep 30, 2024 | $2.05B | +34.7% |
| Q2 FY2024 | Jun 30, 2024 | $1.94B | +45.0% |
| Q1 FY2024 | Mar 31, 2024 | $1.83B | +35.7% |
| Q4 FY2023 | Dec 31, 2023 | $1.65B | +25.0% |
| Q3 FY2023 | Sep 30, 2023 | $1.52B | +38.8% |
| Q2 FY2023 | Jun 30, 2023 | $1.34B | +31.9% |
| Q1 FY2023 | Mar 31, 2023 | $1.35B | +44.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.32B | +53.0% |
| Q3 FY2022 | Sep 30, 2022 | $1.10B | +29.3% |
| Q2 FY2022 | Jun 30, 2022 | $1.01B | +18.2% |
| Q1 FY2022 | Mar 31, 2022 | $933.17M | +10.6% |
| Q4 FY2021 | Dec 31, 2021 | $863.78M | -0.7% |
| Q3 FY2021 | Sep 30, 2021 | $847.82M | -3.6% |
| Q2 FY2021 | Jun 30, 2021 | $857.80M | -2.5% |
| Q1 FY2021 | Mar 31, 2021 | $843.45M | +108.7% |
| Q4 FY2020 | Dec 31, 2020 | $869.82M | +114.3% |
| Q3 FY2020 | Sep 30, 2020 | $879.59M | +118.6% |
| Q2 FY2020 | Jun 30, 2020 | $879.70M | +125.4% |
| Q1 FY2020 | Mar 31, 2020 | $404.13M | -9.0% |
| Q4 FY2019 | Dec 31, 2019 | $405.92M | -7.7% |
| Q3 FY2019 | Sep 30, 2019 | $402.41M | -5.3% |
| Q2 FY2019 | Jun 30, 2019 | $390.25M | -2.9% |
| Q1 FY2019 | Mar 31, 2019 | $443.91M | +13.1% |
| Q4 FY2018 | Dec 31, 2018 | $439.83M | +14.6% |
| Q3 FY2018 | Sep 30, 2018 | $424.82M | +51.2% |
| Q2 FY2018 | Jun 30, 2018 | $401.80M | +50.0% |
| Q1 FY2018 | Mar 31, 2018 | $392.59M | +57.3% |
| Q4 FY2017 | Dec 31, 2017 | $383.86M | +50.0% |
| Q3 FY2017 | Sep 30, 2017 | $281.02M | – |
| Q2 FY2017 | Jun 30, 2017 | $267.88M | – |
| Q1 FY2017 | Mar 31, 2017 | $249.56M | – |
| Q4 FY2016 | Dec 31, 2016 | $255.90M | – |
See a number that looks wrong?